Form 1 R40 INTERVIEW PROTOCOL

OMB Control Number 0915-0335

Expiration Date XX/XX/201X

ATTACHMENT E:

R40 INTERVIEW PROTOCOL

Public Burden Statement:  An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.  The OMB control number for this project is 0915-0335. Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, and completing and reviewing the collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden, to HRSA Reports Clearance Officer, 5600 Fishers Lane, Room 10‑29, Rockville, MD, Maryland, 20857.

SEMI–STRUCTURED INTERVIEW GUIDE

R40: MCH AUTISM INTERVENTION RESEARCH PROGRAM GRANTEES

The purpose of this interview is to obtain descriptive information about your activities and outcomes for the evaluation of MCHB’s Combating Autism Act Initiative. Today, we will be asking you questions on several topic areas which relate to the objectives of the Combating Autism Act Initiative.

Note: This guide is divided into two domains, one for each CAAI goal associated with the R40 Research Program grants. The questions in each domain provide the general topics to cover and not all are applicable to all grantees. As a result, the following guide will be adapted to the activities for a particular grantee. Each discussion will also build on the information that has already been obtained during reviews of program documents.

Conduct Research Leading To Evidence-Based Interventions

First I am going to ask you some questions about your particular research project. We understand that your grant has focused on research leading to improvements in interventions that address the health of children and adolescents with ASD and other DD. [provide description of ongoing research study funded]. Is our understanding accurate?

• What challenges have you faced implementing this research?

• What study populations were focused on? Were you able to reach your target population(s)?

• Please describe the highlights of your findings.

• [If not already discussed], what were your goals for conducting this research?

• Have you met these objectives or goals?

• If yes, how do you know?

• If not, why not?

Disseminate Information to Health Professionals and the Public

Next, I’m going to ask you a few questions about how your study will be disseminated.

• What are the final products resulting from your research?

• What dissemination efforts or activities of these products have been or will be conducted?

• With what types of health professionals or population groups were (or will be) the target audience for your dissemination efforts?

• [If dissemination was conducted]: Which dissemination efforts have been most successful and why?

• What are the challenges associated with disseminating your particular study information?

• What types of things do you hope could happen as a result of your research in this area?

Wrap Up

Is there anything that we haven’t covered?

We will be sending you a document with a profile of your grant program containing information we pulled from your application, progress report, and this interview. We ask that you take some time to read through this to make sure all the information is correct and add in any additional information you think should be included. There will also be spaces on there for you to fill in any articles, publications, presentations, and other outreach or dissemination materials that have been or will be generated as a result of your R40 grant. Please also indicate what stage of progress each product is in (for example: published, submitted, in progress, etc.)

Thank you for your time. We greatly appreciate your assistance.

3